nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—CYP3A4—Rivastigmine—Alzheimer's disease	0.194	0.432	CbGbCtD
Tolvaptan—CYP3A4—Donepezil—Alzheimer's disease	0.155	0.345	CbGbCtD
Tolvaptan—CYP3A4—Galantamine—Alzheimer's disease	0.0999	0.223	CbGbCtD
Tolvaptan—Polydipsia—Donepezil—Alzheimer's disease	0.0131	0.0337	CcSEcCtD
Tolvaptan—Polydipsia—Memantine—Alzheimer's disease	0.0118	0.0306	CcSEcCtD
Tolvaptan—Hypernatraemia—Memantine—Alzheimer's disease	0.00699	0.0181	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Donepezil—Alzheimer's disease	0.00665	0.0172	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Memantine—Alzheimer's disease	0.00604	0.0156	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Memantine—Alzheimer's disease	0.00496	0.0128	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Rivastigmine—Alzheimer's disease	0.00486	0.0126	CcSEcCtD
Tolvaptan—Renal impairment—Galantamine—Alzheimer's disease	0.00398	0.0103	CcSEcCtD
Tolvaptan—Hyperuricaemia—Memantine—Alzheimer's disease	0.00396	0.0102	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00387	0.01	CcSEcCtD
Tolvaptan—Blood uric acid increased—Memantine—Alzheimer's disease	0.00374	0.00967	CcSEcCtD
Tolvaptan—Respiratory failure—Memantine—Alzheimer's disease	0.00374	0.00967	CcSEcCtD
Tolvaptan—Pulmonary embolism—Memantine—Alzheimer's disease	0.00367	0.0095	CcSEcCtD
Tolvaptan—Respiratory failure—Rivastigmine—Alzheimer's disease	0.00366	0.00946	CcSEcCtD
Tolvaptan—Ecchymosis—Donepezil—Alzheimer's disease	0.00366	0.00946	CcSEcCtD
Tolvaptan—Hyperkalaemia—Memantine—Alzheimer's disease	0.00361	0.00933	CcSEcCtD
Tolvaptan—Pulmonary embolism—Rivastigmine—Alzheimer's disease	0.00359	0.00929	CcSEcCtD
Tolvaptan—Dehydration—Galantamine—Alzheimer's disease	0.00352	0.00911	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00346	0.00895	CcSEcCtD
Tolvaptan—Urine output increased—Memantine—Alzheimer's disease	0.00332	0.00858	CcSEcCtD
Tolvaptan—Urine output increased—Rivastigmine—Alzheimer's disease	0.00325	0.0084	CcSEcCtD
Tolvaptan—Thirst—Donepezil—Alzheimer's disease	0.00309	0.00798	CcSEcCtD
Tolvaptan—Polyuria—Memantine—Alzheimer's disease	0.00304	0.00785	CcSEcCtD
Tolvaptan—Pollakiuria—Galantamine—Alzheimer's disease	0.00303	0.00782	CcSEcCtD
Tolvaptan—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00301	0.00778	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.003	0.00775	CcSEcCtD
Tolvaptan—Zafirlukast—PTGS1—Alzheimer's disease	0.00299	0.595	CrCbGaD
Tolvaptan—Polyuria—Rivastigmine—Alzheimer's disease	0.00297	0.00768	CcSEcCtD
Tolvaptan—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00295	0.00764	CcSEcCtD
Tolvaptan—Hyponatraemia—Donepezil—Alzheimer's disease	0.00295	0.00762	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00294	0.00759	CcSEcCtD
Tolvaptan—Renal failure—Galantamine—Alzheimer's disease	0.00287	0.00742	CcSEcCtD
Tolvaptan—Renal impairment—Memantine—Alzheimer's disease	0.0028	0.00724	CcSEcCtD
Tolvaptan—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00275	0.00711	CcSEcCtD
Tolvaptan—Thirst—Rivastigmine—Alzheimer's disease	0.00274	0.00709	CcSEcCtD
Tolvaptan—Renal impairment—Rivastigmine—Alzheimer's disease	0.00274	0.00709	CcSEcCtD
Tolvaptan—Hypoglycaemia—Memantine—Alzheimer's disease	0.00273	0.00706	CcSEcCtD
Tolvaptan—Dehydration—Donepezil—Alzheimer's disease	0.00273	0.00706	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00272	0.00703	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00268	0.00693	CcSEcCtD
Tolvaptan—Hyponatraemia—Memantine—Alzheimer's disease	0.00268	0.00692	CcSEcCtD
Tolvaptan—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00267	0.00691	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.00267	0.00689	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00266	0.00688	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.00264	0.00684	CcSEcCtD
Tolvaptan—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.00262	0.00677	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00261	0.00674	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00259	0.0067	CcSEcCtD
Tolvaptan—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00259	0.00669	CcSEcCtD
Tolvaptan—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00258	0.00666	CcSEcCtD
Tolvaptan—Urethral disorder—Galantamine—Alzheimer's disease	0.00257	0.00664	CcSEcCtD
Tolvaptan—Blood creatinine increased—Memantine—Alzheimer's disease	0.0025	0.00646	CcSEcCtD
Tolvaptan—Dehydration—Memantine—Alzheimer's disease	0.00248	0.00641	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00244	0.0063	CcSEcCtD
Tolvaptan—Cardiac disorder—Galantamine—Alzheimer's disease	0.00243	0.00629	CcSEcCtD
Tolvaptan—Dehydration—Rivastigmine—Alzheimer's disease	0.00243	0.00627	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.0024	0.00621	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00238	0.00616	CcSEcCtD
Tolvaptan—Angiopathy—Galantamine—Alzheimer's disease	0.00238	0.00615	CcSEcCtD
Tolvaptan—Immune system disorder—Galantamine—Alzheimer's disease	0.00237	0.00612	CcSEcCtD
Tolvaptan—Breast disorder—Rivastigmine—Alzheimer's disease	0.00236	0.00609	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00235	0.00608	CcSEcCtD
Tolvaptan—Pollakiuria—Donepezil—Alzheimer's disease	0.00234	0.00606	CcSEcCtD
Tolvaptan—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00229	0.00592	CcSEcCtD
Tolvaptan—Malnutrition—Galantamine—Alzheimer's disease	0.00228	0.0059	CcSEcCtD
Tolvaptan—Dysgeusia—Galantamine—Alzheimer's disease	0.00223	0.00578	CcSEcCtD
Tolvaptan—Renal failure—Donepezil—Alzheimer's disease	0.00222	0.00575	CcSEcCtD
Tolvaptan—Pollakiuria—Memantine—Alzheimer's disease	0.00213	0.0055	CcSEcCtD
Tolvaptan—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00212	0.00547	CcSEcCtD
Tolvaptan—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00208	0.00538	CcSEcCtD
Tolvaptan—Hyperglycaemia—Memantine—Alzheimer's disease	0.00208	0.00537	CcSEcCtD
Tolvaptan—Malaise—Galantamine—Alzheimer's disease	0.00206	0.00532	CcSEcCtD
Tolvaptan—Syncope—Galantamine—Alzheimer's disease	0.00205	0.00529	CcSEcCtD
Tolvaptan—Zafirlukast—CYP2D6—Alzheimer's disease	0.00204	0.405	CrCbGaD
Tolvaptan—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00203	0.00526	CcSEcCtD
Tolvaptan—Renal failure—Memantine—Alzheimer's disease	0.00202	0.00522	CcSEcCtD
Tolvaptan—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00201	0.00519	CcSEcCtD
Tolvaptan—Loss of consciousness—Galantamine—Alzheimer's disease	0.00201	0.00518	CcSEcCtD
Tolvaptan—Urethral disorder—Donepezil—Alzheimer's disease	0.00199	0.00515	CcSEcCtD
Tolvaptan—Renal failure—Rivastigmine—Alzheimer's disease	0.00198	0.00511	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00193	0.00499	CcSEcCtD
Tolvaptan—Discomfort—Galantamine—Alzheimer's disease	0.00192	0.00496	CcSEcCtD
Tolvaptan—Dry mouth—Galantamine—Alzheimer's disease	0.0019	0.00491	CcSEcCtD
Tolvaptan—AVPR1A—central nervous system—Alzheimer's disease	0.00188	0.179	CbGeAlD
Tolvaptan—Shock—Galantamine—Alzheimer's disease	0.00183	0.00474	CcSEcCtD
Tolvaptan—Nervous system disorder—Galantamine—Alzheimer's disease	0.00183	0.00472	CcSEcCtD
Tolvaptan—Urinary tract disorder—Memantine—Alzheimer's disease	0.00182	0.00471	CcSEcCtD
Tolvaptan—Connective tissue disorder—Memantine—Alzheimer's disease	0.00181	0.00469	CcSEcCtD
Tolvaptan—Skin disorder—Galantamine—Alzheimer's disease	0.00181	0.00468	CcSEcCtD
Tolvaptan—Urethral disorder—Memantine—Alzheimer's disease	0.00181	0.00467	CcSEcCtD
Tolvaptan—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00178	0.00461	CcSEcCtD
Tolvaptan—Anorexia—Galantamine—Alzheimer's disease	0.00178	0.00459	CcSEcCtD
Tolvaptan—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00177	0.00458	CcSEcCtD
Tolvaptan—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00177	0.00457	CcSEcCtD
Tolvaptan—Malnutrition—Donepezil—Alzheimer's disease	0.00177	0.00457	CcSEcCtD
Tolvaptan—Dysgeusia—Donepezil—Alzheimer's disease	0.00173	0.00448	CcSEcCtD
Tolvaptan—Cardiac disorder—Memantine—Alzheimer's disease	0.00171	0.00443	CcSEcCtD
Tolvaptan—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00167	0.00433	CcSEcCtD
Tolvaptan—Angiopathy—Memantine—Alzheimer's disease	0.00167	0.00433	CcSEcCtD
Tolvaptan—Immune system disorder—Memantine—Alzheimer's disease	0.00167	0.00431	CcSEcCtD
Tolvaptan—Mediastinal disorder—Memantine—Alzheimer's disease	0.00166	0.0043	CcSEcCtD
Tolvaptan—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00164	0.00424	CcSEcCtD
Tolvaptan—Angiopathy—Rivastigmine—Alzheimer's disease	0.00164	0.00423	CcSEcCtD
Tolvaptan—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00163	0.0042	CcSEcCtD
Tolvaptan—Decreased appetite—Galantamine—Alzheimer's disease	0.00162	0.00419	CcSEcCtD
Tolvaptan—AVPR2—nervous system—Alzheimer's disease	0.00162	0.154	CbGeAlD
Tolvaptan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00161	0.00416	CcSEcCtD
Tolvaptan—Malnutrition—Memantine—Alzheimer's disease	0.00161	0.00415	CcSEcCtD
Tolvaptan—Malaise—Donepezil—Alzheimer's disease	0.00159	0.00412	CcSEcCtD
Tolvaptan—Constipation—Galantamine—Alzheimer's disease	0.00159	0.00412	CcSEcCtD
Tolvaptan—Syncope—Donepezil—Alzheimer's disease	0.00159	0.0041	CcSEcCtD
Tolvaptan—Dysgeusia—Memantine—Alzheimer's disease	0.00157	0.00406	CcSEcCtD
Tolvaptan—Malnutrition—Rivastigmine—Alzheimer's disease	0.00157	0.00406	CcSEcCtD
Tolvaptan—AVPR2—central nervous system—Alzheimer's disease	0.00156	0.148	CbGeAlD
Tolvaptan—Loss of consciousness—Donepezil—Alzheimer's disease	0.00155	0.00402	CcSEcCtD
Tolvaptan—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00154	0.00398	CcSEcCtD
Tolvaptan—Feeling abnormal—Galantamine—Alzheimer's disease	0.00153	0.00397	CcSEcCtD
Tolvaptan—AVPR1A—brain—Alzheimer's disease	0.00149	0.142	CbGeAlD
Tolvaptan—Ill-defined disorder—Memantine—Alzheimer's disease	0.00149	0.00385	CcSEcCtD
Tolvaptan—Discomfort—Donepezil—Alzheimer's disease	0.00149	0.00385	CcSEcCtD
Tolvaptan—Dry mouth—Donepezil—Alzheimer's disease	0.00147	0.00381	CcSEcCtD
Tolvaptan—Body temperature increased—Galantamine—Alzheimer's disease	0.00147	0.00381	CcSEcCtD
Tolvaptan—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00146	0.00377	CcSEcCtD
Tolvaptan—Malaise—Memantine—Alzheimer's disease	0.00145	0.00374	CcSEcCtD
Tolvaptan—Syncope—Memantine—Alzheimer's disease	0.00144	0.00372	CcSEcCtD
Tolvaptan—Shock—Donepezil—Alzheimer's disease	0.00142	0.00367	CcSEcCtD
Tolvaptan—Malaise—Rivastigmine—Alzheimer's disease	0.00142	0.00366	CcSEcCtD
Tolvaptan—Nervous system disorder—Donepezil—Alzheimer's disease	0.00142	0.00366	CcSEcCtD
Tolvaptan—Loss of consciousness—Memantine—Alzheimer's disease	0.00141	0.00365	CcSEcCtD
Tolvaptan—Syncope—Rivastigmine—Alzheimer's disease	0.00141	0.00364	CcSEcCtD
Tolvaptan—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00138	0.00357	CcSEcCtD
Tolvaptan—Anorexia—Donepezil—Alzheimer's disease	0.00138	0.00356	CcSEcCtD
Tolvaptan—Hypersensitivity—Galantamine—Alzheimer's disease	0.00137	0.00355	CcSEcCtD
Tolvaptan—Discomfort—Memantine—Alzheimer's disease	0.00135	0.00349	CcSEcCtD
Tolvaptan—Dry mouth—Memantine—Alzheimer's disease	0.00134	0.00346	CcSEcCtD
Tolvaptan—Asthenia—Galantamine—Alzheimer's disease	0.00134	0.00345	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00133	0.00343	CcSEcCtD
Tolvaptan—Discomfort—Rivastigmine—Alzheimer's disease	0.00132	0.00342	CcSEcCtD
Tolvaptan—Dry mouth—Rivastigmine—Alzheimer's disease	0.00131	0.00338	CcSEcCtD
Tolvaptan—Shock—Memantine—Alzheimer's disease	0.00129	0.00333	CcSEcCtD
Tolvaptan—Nervous system disorder—Memantine—Alzheimer's disease	0.00129	0.00332	CcSEcCtD
Tolvaptan—Diarrhoea—Galantamine—Alzheimer's disease	0.00127	0.00329	CcSEcCtD
Tolvaptan—Skin disorder—Memantine—Alzheimer's disease	0.00127	0.00329	CcSEcCtD
Tolvaptan—Shock—Rivastigmine—Alzheimer's disease	0.00126	0.00326	CcSEcCtD
Tolvaptan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00126	0.00325	CcSEcCtD
Tolvaptan—Decreased appetite—Donepezil—Alzheimer's disease	0.00125	0.00324	CcSEcCtD
Tolvaptan—Anorexia—Memantine—Alzheimer's disease	0.00125	0.00323	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00125	0.00322	CcSEcCtD
Tolvaptan—Skin disorder—Rivastigmine—Alzheimer's disease	0.00125	0.00322	CcSEcCtD
Tolvaptan—AVPR2—brain—Alzheimer's disease	0.00124	0.118	CbGeAlD
Tolvaptan—Constipation—Donepezil—Alzheimer's disease	0.00123	0.00319	CcSEcCtD
Tolvaptan—Dizziness—Galantamine—Alzheimer's disease	0.00123	0.00318	CcSEcCtD
Tolvaptan—Anorexia—Rivastigmine—Alzheimer's disease	0.00122	0.00316	CcSEcCtD
Tolvaptan—Feeling abnormal—Donepezil—Alzheimer's disease	0.00119	0.00307	CcSEcCtD
Tolvaptan—Headache—Galantamine—Alzheimer's disease	0.00117	0.00302	CcSEcCtD
Tolvaptan—Body temperature increased—Donepezil—Alzheimer's disease	0.00114	0.00295	CcSEcCtD
Tolvaptan—Decreased appetite—Memantine—Alzheimer's disease	0.00114	0.00294	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00113	0.00292	CcSEcCtD
Tolvaptan—Constipation—Memantine—Alzheimer's disease	0.00112	0.0029	CcSEcCtD
Tolvaptan—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00111	0.00288	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00111	0.00286	CcSEcCtD
Tolvaptan—Nausea—Galantamine—Alzheimer's disease	0.00111	0.00286	CcSEcCtD
Tolvaptan—Constipation—Rivastigmine—Alzheimer's disease	0.0011	0.00283	CcSEcCtD
Tolvaptan—Feeling abnormal—Memantine—Alzheimer's disease	0.00108	0.00279	CcSEcCtD
Tolvaptan—Hypersensitivity—Donepezil—Alzheimer's disease	0.00106	0.00275	CcSEcCtD
Tolvaptan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00106	0.00273	CcSEcCtD
Tolvaptan—Body temperature increased—Memantine—Alzheimer's disease	0.00104	0.00268	CcSEcCtD
Tolvaptan—Asthenia—Donepezil—Alzheimer's disease	0.00104	0.00268	CcSEcCtD
Tolvaptan—Pruritus—Donepezil—Alzheimer's disease	0.00102	0.00264	CcSEcCtD
Tolvaptan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00101	0.00262	CcSEcCtD
Tolvaptan—Diarrhoea—Donepezil—Alzheimer's disease	0.000988	0.00255	CcSEcCtD
Tolvaptan—Hypersensitivity—Memantine—Alzheimer's disease	0.000966	0.0025	CcSEcCtD
Tolvaptan—Dizziness—Donepezil—Alzheimer's disease	0.000955	0.00247	CcSEcCtD
Tolvaptan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000945	0.00244	CcSEcCtD
Tolvaptan—Asthenia—Memantine—Alzheimer's disease	0.00094	0.00243	CcSEcCtD
Tolvaptan—Pruritus—Memantine—Alzheimer's disease	0.000927	0.0024	CcSEcCtD
Tolvaptan—Asthenia—Rivastigmine—Alzheimer's disease	0.00092	0.00238	CcSEcCtD
Tolvaptan—Pruritus—Rivastigmine—Alzheimer's disease	0.000907	0.00234	CcSEcCtD
Tolvaptan—Headache—Donepezil—Alzheimer's disease	0.000904	0.00234	CcSEcCtD
Tolvaptan—Diarrhoea—Memantine—Alzheimer's disease	0.000897	0.00232	CcSEcCtD
Tolvaptan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000877	0.00227	CcSEcCtD
Tolvaptan—Dizziness—Memantine—Alzheimer's disease	0.000867	0.00224	CcSEcCtD
Tolvaptan—Nausea—Donepezil—Alzheimer's disease	0.000857	0.00222	CcSEcCtD
Tolvaptan—Dizziness—Rivastigmine—Alzheimer's disease	0.000848	0.00219	CcSEcCtD
Tolvaptan—Headache—Memantine—Alzheimer's disease	0.000821	0.00212	CcSEcCtD
Tolvaptan—Headache—Rivastigmine—Alzheimer's disease	0.000803	0.00208	CcSEcCtD
Tolvaptan—Nausea—Memantine—Alzheimer's disease	0.000778	0.00201	CcSEcCtD
Tolvaptan—Nausea—Rivastigmine—Alzheimer's disease	0.000762	0.00197	CcSEcCtD
Tolvaptan—ABCB1—blood vessel—Alzheimer's disease	0.000608	0.058	CbGeAlD
Tolvaptan—ABCB1—embryo—Alzheimer's disease	0.000363	0.0346	CbGeAlD
Tolvaptan—ABCB1—forebrain—Alzheimer's disease	0.000321	0.0306	CbGeAlD
Tolvaptan—ABCB1—telencephalon—Alzheimer's disease	0.000295	0.0281	CbGeAlD
Tolvaptan—CYP3A4—nervous system—Alzheimer's disease	0.000246	0.0235	CbGeAlD
Tolvaptan—AVPR1A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000239	0.00161	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GAB2—Alzheimer's disease	0.000237	0.0016	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—SST—Alzheimer's disease	0.000237	0.0016	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000237	0.00159	CbGpPWpGaD
Tolvaptan—CYP3A4—central nervous system—Alzheimer's disease	0.000237	0.0226	CbGeAlD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	0.000236	0.00158	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000233	0.00157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—APP—Alzheimer's disease	0.000233	0.00157	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—APP—Alzheimer's disease	0.000231	0.00155	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL2—Alzheimer's disease	0.00023	0.00154	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL2—Alzheimer's disease	0.000228	0.00153	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000227	0.00153	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PSENEN—Alzheimer's disease	0.000225	0.00151	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PSENEN—Alzheimer's disease	0.000224	0.0015	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000223	0.0015	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APH1A—Alzheimer's disease	0.000222	0.00149	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APH1A—Alzheimer's disease	0.000221	0.00148	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.00022	0.00148	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	0.00022	0.00148	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000218	0.00147	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000216	0.00145	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000216	0.00145	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000215	0.00144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NCSTN—Alzheimer's disease	0.000215	0.00144	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LRP1—Alzheimer's disease	0.000211	0.00142	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LRP1—Alzheimer's disease	0.00021	0.00141	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000209	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GAL—Alzheimer's disease	0.000206	0.00138	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GFAP—Alzheimer's disease	0.000206	0.00138	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GAL—Alzheimer's disease	0.000205	0.00138	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GFAP—Alzheimer's disease	0.000205	0.00138	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	0.000202	0.00136	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000196	0.00131	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000192	0.00129	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—A2M—Alzheimer's disease	0.000182	0.00122	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000181	0.00122	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—A2M—Alzheimer's disease	0.00018	0.00121	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000179	0.0012	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000178	0.00119	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000176	0.00118	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PSEN2—Alzheimer's disease	0.000175	0.00117	CbGpPWpGaD
Tolvaptan—ABCB1—nervous system—Alzheimer's disease	0.000174	0.0166	CbGeAlD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.00017	0.00114	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.00017	0.00114	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000168	0.00113	CbGpPWpGaD
Tolvaptan—ABCB1—central nervous system—Alzheimer's disease	0.000168	0.016	CbGeAlD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000167	0.00113	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000166	0.00112	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000165	0.00111	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000164	0.0011	CbGpPWpGaD
Tolvaptan—ABCB1—cerebellum—Alzheimer's disease	0.000164	0.0156	CbGeAlD
Tolvaptan—AVPR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000163	0.00109	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NPY—Alzheimer's disease	0.000162	0.00109	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000161	0.00108	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IAPP—Alzheimer's disease	0.000161	0.00108	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NPY—Alzheimer's disease	0.000161	0.00108	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IAPP—Alzheimer's disease	0.00016	0.00107	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000159	0.00107	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CRH—Alzheimer's disease	0.000156	0.00105	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CRH—Alzheimer's disease	0.000155	0.00104	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000154	0.00104	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCR5—Alzheimer's disease	0.000153	0.00103	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000151	0.00101	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR2A—Alzheimer's disease	0.00015	0.00101	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NPS—Alzheimer's disease	0.000148	0.000995	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000147	0.00099	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NPS—Alzheimer's disease	0.000147	0.000988	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000146	0.000983	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—F2—Alzheimer's disease	0.000146	0.000978	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000145	0.000976	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—F2—Alzheimer's disease	0.000145	0.000971	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTK2B—Alzheimer's disease	0.000144	0.000969	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GAB2—Alzheimer's disease	0.000141	0.000949	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SST—Alzheimer's disease	0.000141	0.000949	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000141	0.000949	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000141	0.000945	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GAB2—Alzheimer's disease	0.00014	0.000942	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SST—Alzheimer's disease	0.00014	0.000942	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NTRK2—Alzheimer's disease	0.00014	0.000942	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GSK3A—Alzheimer's disease	0.00014	0.000941	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00014	0.000939	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CALM1—Alzheimer's disease	0.00014	0.000939	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GSK3A—Alzheimer's disease	0.000139	0.000934	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APP—Alzheimer's disease	0.000138	0.000925	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APP—Alzheimer's disease	0.000137	0.000918	CbGpPWpGaD
Tolvaptan—ABCB1—brain—Alzheimer's disease	0.000133	0.0127	CbGeAlD
Tolvaptan—AVPR1A—Signaling by GPCR—F2—Alzheimer's disease	0.000132	0.000888	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—F2—Alzheimer's disease	0.000131	0.000882	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	0.00013	0.000874	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PLCB1—Alzheimer's disease	0.00013	0.000873	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	0.00013	0.000872	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PLCB1—Alzheimer's disease	0.000129	0.000867	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000128	0.000862	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	0.000127	0.000855	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NGFR—Alzheimer's disease	0.000121	0.000814	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	0.000121	0.000811	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CREB1—Alzheimer's disease	0.00012	0.000809	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NGFR—Alzheimer's disease	0.00012	0.000809	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CREB1—Alzheimer's disease	0.00012	0.000803	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000119	0.000802	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000118	0.000795	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	0.000118	0.000795	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000118	0.000792	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADAM10—Alzheimer's disease	0.000118	0.00079	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL2—Alzheimer's disease	0.000117	0.000786	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000117	0.000784	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—S100B—Alzheimer's disease	0.000112	0.000752	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—S100B—Alzheimer's disease	0.000111	0.000747	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DHCR24—Alzheimer's disease	0.000111	0.000746	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	0.00011	0.00074	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF2—Alzheimer's disease	0.000107	0.000716	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF2—Alzheimer's disease	0.000106	0.000711	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000103	0.000692	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1R—Alzheimer's disease	0.000102	0.000687	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	0.000101	0.000679	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LPL—Alzheimer's disease	9.88e-05	0.000664	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LPL—Alzheimer's disease	9.81e-05	0.000659	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MEF2C—Alzheimer's disease	9.79e-05	0.000658	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MEF2C—Alzheimer's disease	9.72e-05	0.000653	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	9.62e-05	0.000646	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKCG—Alzheimer's disease	9.61e-05	0.000646	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKCG—Alzheimer's disease	9.54e-05	0.000641	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	9.44e-05	0.000634	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CA4—Alzheimer's disease	9.44e-05	0.000634	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NGF—Alzheimer's disease	9.36e-05	0.000629	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NGF—Alzheimer's disease	9.29e-05	0.000624	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR5—Alzheimer's disease	9.1e-05	0.000612	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR5—Alzheimer's disease	9.04e-05	0.000607	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR2A—Alzheimer's disease	8.91e-05	0.000599	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	8.88e-05	0.000596	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR2A—Alzheimer's disease	8.85e-05	0.000594	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	8.77e-05	0.000589	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	8.65e-05	0.000581	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	8.41e-05	0.000565	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	8.32e-05	0.000559	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CALM1—Alzheimer's disease	8.31e-05	0.000558	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LEP—Alzheimer's disease	8.28e-05	0.000556	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOE—Alzheimer's disease	8.28e-05	0.000556	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CALM1—Alzheimer's disease	8.25e-05	0.000554	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOE—Alzheimer's disease	8.22e-05	0.000552	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LEP—Alzheimer's disease	8.22e-05	0.000552	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CAV1—Alzheimer's disease	8.21e-05	0.000551	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CAV1—Alzheimer's disease	8.15e-05	0.000547	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	8.12e-05	0.000545	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLD3—Alzheimer's disease	8.03e-05	0.000539	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ESR1—Alzheimer's disease	7.91e-05	0.000531	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ESR1—Alzheimer's disease	7.85e-05	0.000527	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—F2—Alzheimer's disease	7.81e-05	0.000525	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—F2—Alzheimer's disease	7.75e-05	0.000521	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	7.7e-05	0.000517	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	7.64e-05	0.000514	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH1—Alzheimer's disease	7.59e-05	0.00051	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.46e-05	0.000501	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	7.41e-05	0.000498	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	7.27e-05	0.000488	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GSK3B—Alzheimer's disease	7.17e-05	0.000482	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ND1—Alzheimer's disease	7.15e-05	0.000481	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GSK3B—Alzheimer's disease	7.12e-05	0.000478	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CREB1—Alzheimer's disease	7.12e-05	0.000478	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INS—Alzheimer's disease	7.08e-05	0.000475	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CREB1—Alzheimer's disease	7.06e-05	0.000475	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INS—Alzheimer's disease	7.03e-05	0.000472	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—Alzheimer's disease	6.96e-05	0.000468	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—Alzheimer's disease	6.91e-05	0.000464	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	6.9e-05	0.000464	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—Alzheimer's disease	6.84e-05	0.00046	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	6.84e-05	0.00046	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—Alzheimer's disease	6.8e-05	0.000457	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	6.41e-05	0.00043	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—Alzheimer's disease	6.21e-05	0.000417	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—Alzheimer's disease	6.16e-05	0.000414	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	5.89e-05	0.000396	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA4—Alzheimer's disease	5.82e-05	0.000391	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	5.47e-05	0.000367	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	5.44e-05	0.000365	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.32e-05	0.000357	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.28e-05	0.000355	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—Alzheimer's disease	5.27e-05	0.000354	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—Alzheimer's disease	5.23e-05	0.000352	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—Alzheimer's disease	5.23e-05	0.000351	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.22e-05	0.000351	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—Alzheimer's disease	5.2e-05	0.000349	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	5.18e-05	0.000348	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	4.99e-05	0.000335	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.95e-05	0.000332	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK8—Alzheimer's disease	4.84e-05	0.000325	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—Alzheimer's disease	4.83e-05	0.000324	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK8—Alzheimer's disease	4.81e-05	0.000323	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—Alzheimer's disease	4.79e-05	0.000322	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	4.74e-05	0.000319	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	4.66e-05	0.000313	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CHAT—Alzheimer's disease	4.61e-05	0.00031	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TPI1—Alzheimer's disease	4.61e-05	0.00031	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	4.56e-05	0.000307	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—Alzheimer's disease	4.47e-05	0.0003	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—Alzheimer's disease	4.44e-05	0.000298	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MAOB—Alzheimer's disease	4.42e-05	0.000297	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ND1—Alzheimer's disease	4.41e-05	0.000296	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GAPDH—Alzheimer's disease	4.25e-05	0.000286	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—A2M—Alzheimer's disease	4.11e-05	0.000276	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	4.11e-05	0.000276	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—Alzheimer's disease	4.1e-05	0.000276	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—Alzheimer's disease	4.07e-05	0.000274	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ACHE—Alzheimer's disease	3.57e-05	0.00024	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—INPP5D—Alzheimer's disease	3.53e-05	0.000237	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.47e-05	0.000233	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—Alzheimer's disease	3.38e-05	0.000227	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—Alzheimer's disease	3.35e-05	0.000225	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ENO1—Alzheimer's disease	3.35e-05	0.000225	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS1—Alzheimer's disease	3.35e-05	0.000225	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	3.28e-05	0.000221	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BCHE—Alzheimer's disease	3.11e-05	0.000209	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—Alzheimer's disease	3.09e-05	0.000208	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—Alzheimer's disease	3.07e-05	0.000206	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLCB1—Alzheimer's disease	2.94e-05	0.000197	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—Alzheimer's disease	2.85e-05	0.000192	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCA1—Alzheimer's disease	2.85e-05	0.000191	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.84e-05	0.000191	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.84e-05	0.000191	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—Alzheimer's disease	2.83e-05	0.00019	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.72e-05	0.000183	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.62e-05	0.000176	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.53e-05	0.00017	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.45e-05	0.000165	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.44e-05	0.000164	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPL—Alzheimer's disease	2.23e-05	0.00015	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.2e-05	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.18e-05	0.000146	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.06e-05	0.000139	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.06e-05	0.000139	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.02e-05	0.000136	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.01e-05	0.000135	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.92e-05	0.000129	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.88e-05	0.000126	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOE—Alzheimer's disease	1.87e-05	0.000126	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.86e-05	0.000125	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.81e-05	0.000122	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.75e-05	0.000118	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.63e-05	0.00011	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—INS—Alzheimer's disease	1.6e-05	0.000108	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.51e-05	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.51e-05	0.000101	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.4e-05	9.43e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.38e-05	9.25e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.28e-05	8.62e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.24e-05	8.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.16e-05	7.78e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.15e-05	7.75e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.14e-05	7.68e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.01e-05	6.75e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—INS—Alzheimer's disease	9.86e-06	6.62e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—Alzheimer's disease	8.65e-06	5.81e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	7.91e-06	5.31e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—Alzheimer's disease	6.45e-06	4.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.97e-06	2.67e-05	CbGpPWpGaD
